|
1
|
Broderick JM, Bruce-Brand R, Stanley E and
Mulhall KJ: Osteoporotic hip fractures: The burden of fixation
failure. ScientificWorldJournal. 2013:5151972013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singer A, Exuzides A, Spangler L, O'Malley
C, Colby C, Johnston K, Agodoa I, Baker J and Kagan R: Burden of
illness for osteoporotic fractures compared with other serious
diseases among postmenopausal women in the United States. Mayo Clin
Proc. 90:53–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McCann RM, Colleary G, Geddis C, Clarke
SA, Jordan GR, Dickson GR and Marsh D: Effect of osteoporosis on
bone mineral density and fracture repair in a rat femoral fracture
model. J Orthop Res. 26:384–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldhahn J, Féron JM, Kanis J, Papapoulos
S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y and
Boonen S: Implications for fracture healing of current and new
osteoporosis treatments: An ESCEO consensus paper. Calcif Tissue
Int. 90:343–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watson JT and Nicolaou DA: Orthobiologics
in the augmentation of osteoporotic fractures. Curr Osteoporos Rep.
13:22–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
U.S. Food and Drug Administration, .
InFuse TM Bone Graft/LT-CAGETM lumbar tapered fusion
device-P000058. 2002.https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P000058January
23–2014
|
|
7
|
Sarban S, Senkoylu A, Isikan UE, Korkusuz
P and Korkusuz F: Can rhBMP-2 containing collagen sponges enhance
bone repair in ovariectomized rats? A preliminary study. Clin
Orthop Relat Res. 467:3113–3120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park SB, Park SH, Kim NH and Chung CK:
BMP-2 induced early bone formation in spine fusion using rat
ovariectomy osteoporosis model. Spine J. 13:1273–1280. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zarrinkalam MR, Schultz CG, Ardern DW,
Vernon-Roberts B and Moore RJ: Recombinant human bone morphogenetic
protein-type 2 (rhBMP-2) enhances local bone formation in the
lumbar spine of osteoporotic sheep. J Orthop Res. 31:1390–1397.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boden SD, Kang J, Sandhu H and Heller JG:
Use of recombinant human bone morphogenetic protein-2 to achieve
posterolateral lumbar spine fusion in humans: A prospective,
randomized clinical pilot trial: 2002 volvo award in clinical
studies. Spine (Phila Pa 1976). 27:2662–2673. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hurlbert RJ, Alexander D, Bailey S, Mahood
J, Abraham E, McBroom R, Jodoin A and Fisher C: Rhbmp-2 for
posterolateral instrumented lumbar fusion: A multicenter
prospective randomized controlled trial. Spine (Phila Pa 1976).
38:2139–2148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bess S, Line BG, Lafage V, Schwab F,
Shaffrey CI, Hart RA, Boachie-Adjei O, Akbarnia BA, Ames CP, Burton
DC, et al: Does recombinant human bone morphogenetic protein-2 use
in adult spinal deformity increase complications and are
complications associated with location of rhBMP-2 use? A
prospective, multicenter study of 279 consecutive patients. Spine
(Phila Pa 1976). 39:233–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Simmonds MC, Brown JV, Heirs MK, Higgins
JP, Mannion RJ, Rodgers MA and Stewart LA: Safety and effectiveness
of recombinant human bone morphogenetic protein-2 for spinal
fusion: A meta-analysis of individual-participant data. Ann Intern
Med. 158:877–889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faundez A, Tournier C, Garcia M, Aunoble S
and Le Huec JC: Bone morphogenetic protein use in spine
surgery-complications and outcomes: A systematic review. Int
Orthop. 40:1309–1319. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kyllönen L, D'Este M, Alini M and Eglin D:
Local drug delivery for enhancing fracture healing in osteoporotic
bone. Acta Biomater. 11:412–434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu NY, Gdalevitch M, Murphy CM, Mikulec K,
Peacock L, Fitzpatrick J, Cantrill LC, Ruys AJ, Cooper-White JJ,
Little DG and Schindeler A: Spatial control of bone formation using
a porous polymer scaffold co-delivering anabolic rhBMP-2 and
anti-resorptive agents. Eur Cell Mater. 27:98–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Larsson S and Fazzalari NL:
Anti-osteoporosis therapy and fracture healing. Arch Orthop Trauma
Surg. 134:291–297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hegde V, Jo JE, Andreopoulou P and Lane
JM: Effect of osteoporosis medications on fracture healing.
Osteoporos Int. 27:861–871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Huang JH, Liu SF, Zhao YJ, Shen
ZY, Wang YJ and Bian Q: The osteoprotective effect of psoralen in
ovariectomy-induced osteoporotic rats via stimulating the
osteoblastic differentiation from bone mesenchymal stem cells.
Menopause. 19:1156–1164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan X, Bi Y, Yan Z, Pu Q, Li Y and Zhou
K: Psoralen and isopsoralen ameliorate sex hormone
deficiency-induced osteoporosis in female and male mice. Biomed Res
Int. 2016:68694522016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manigrasso MB and O'Connor JP: Comparison
of fracture healing among different inbred mouse strains. Calcif
Tissue Int. 82:465–474. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murnaghan M, Mcllmurray L, Mushipe MT and
Li G: Time for treating bone fracture using rhBMP-2: A randomised
placebo controlled mouse fracture trial. J Orthop Res. 23:625–631.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toupadakis CA, Granick JL, Sagy M, Wong A,
Ghassemi E, Chung DJ, Borjesson DL and Yellowley CE: mobilization
of endogenous stem cell populations enhances fracture healing in a
murine femoral fracture model. Cytotherapy. 15:1136–1147. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bouxsein ML, Boyd SK, Christiansen BA,
Guldberg RE, Jepsen KJ and Müller R: Guidelines for assessment of
bone microstructure in rodents using micro-computed tomography. J
Bone Miner Res. 25:1468–1486. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Toğral G, Arikan M, Korkusuz P, Hesar RH
and Ekşioğlu MF: Positive effect of tadalafil, a
phosphodiesterase-5 inhibitor, on fracture healing in rat femur.
Eklem Hastalik Cerrahisi. 26:137–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Manigrasso MB and O'Connor JP:
Characterization of a closed femur fracture model in mice. J Orthop
Trauma. 18:687–695. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheung WH, Miclau T, Chow SK, Yang FF and
Alt V: Fracture healing in osteoporotic bone. Injury. 47
Suppl:S21–S26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tarantino U, Cerocchi I, Scialdoni A,
Saturnino L, Feola M, Celi M, Liuni FM, Iolascon G and Gasbarra E:
Bone healing and osteoporosis. Aging Clin Exp Res. 23:62–64.
2011.PubMed/NCBI
|
|
29
|
Kanakaris NK, Petsatodis G, Tagil M and
Giannoudis PV: Is there a role for bone morphogenetic proteins in
osteoporotic fractures? Injury. 40 Suppl:S21–S26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Lieshout EM and Alt V: Bone graft
substitutes and bone morphogenetic proteins for osteoporotic
fractures: What is the evidence? Injury. 47 Suppl:S43–S46. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Girgis CM, Sher D and Seibel MJ: Atypical
femoral fractures and bisphosphonate use. N Engl J Med.
362:1848–1849. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Savaridas T, Wallace RJ, Salter DM and
Simpson AH: Do bisphosphonates inhibit direct fracture healing?: A
laboratory investigation using an animal model. Bone Joint J.
95:1263–1268. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ha KY, Park KS, Kim SI and Kim YH: Does
bisphosphonate-based anti-osteoporosis medication affect
osteoporotic spinal fracture healing? Osteoporos Int. 27:483–488.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Leung PC and Siu WS: Herbal treatment for
osteoporosis: A current review. J Tradit Complement Med. 3:82–87.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
An J, Yang H, Zhang Q, Liu C, Zhao J,
Zhang L and Chen B: Natural products for treatment of osteoporosis:
The effects and mechanisms on promoting osteoblast-mediated bone
formation. Life Sci. 147:46–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang DZ, Yang F, Yang Z, Huang J, Shi Q,
Chen D and Wang YJ: Psoralen stimulates osteoblast differentiation
through activation of bmp signaling. Biochem Biophys Res Commun.
405:256–261. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kanatani M, Sugimoto T, Kaji H, Kobayashi
T, Nishiyama K, Fukase M, Kumegawa M and Chihara K: Stimulatory
effect of bone morphogenetic protein-2 on osteoclast-like cell
formation and bone-resorbing activity. J Bone Miner Res.
10:1681–1690. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Okamoto M, Murai J, Yoshikawa H and
Tsumaki N: Bone morphogenetic proteins in bone stimulate
osteoclasts and osteoblasts during bone development. J Bone Miner
Res. 21:1022–1033. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Seeherman HJ, Li XJ, Gavin D, Wozney JM
and Bouxsein ML: Bisphosphonate limits initial bone resorption
without decreasing bone induction in rhBMP-2/ACS treated nonhuman
primate core defects. Bone. 30 Suppl:44S. 2002.
|
|
40
|
Zhang WJ, Xie BP, Li WJ, Li JP, Gan GX and
Zhang J: Inhibitory effect of psoralen on osteoclast formation and
its underling mechanism in vitro. J Third Milit Med Univ.
39:641–645. 2017.(In Chinese).
|
|
41
|
Wang JH, Guo M, Zheng L and Wang Z:
Effects of psoralen on osteoporogeterin and receptor activator
nuclear factor kappa B ligand mRNA expression in rat osteoblasts.
Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 14:6927–6930.
2010.(In Chinese).
|
